Results 281 to 290 of about 351,718 (359)

Impact of early palliative care intervention in autologous bone marrow transplantation: feasibility of a multicentric study. [PDF]

BMC Palliat Care
Argüello-Marina M, Callejas-Charavía M, Merchán-Muñoz B, Gainza-Miranda D, Rico-Zampetti A, Pérez-Maganto R, Ruiz-Ares G, García-Ramírez P, de Miguel-Llorente D, García-Suárez J.   +9 more
europepmc   +1 more source

AUTOIMMUNITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION A STUDY OF 53 LONG-TERM-SURVIVING PATIENTS

, 1988
A M Rouquette-Gally, D. Boyeldieu, A Prost, E Gluckman   +3 more
openalex   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

A Case Report of Neuroleukemiosis Detected on FDG PET Scan in a Patient of Mixed Phenotype Acute Leukemia Post Bone Marrow Transplantation in Remission. [PDF]

World J Nucl Med
Soundararajan R, Yadav A, Avs AK, Jangir H.   +3 more
europepmc   +1 more source

[Indications for bone marrow transplantation].

Revista de medicina de la Universidad de Navarra, 1994
Hernández, M. (M.), Rifon, J. J. (Jose J.), Rocha, E. (Eduardo), Panizo, C. (Carlos), Hermida, J. (José), Cuesta, B. (Braulia), Prosper-Cardoso, F. (Felipe)   +6 more
openaire   +2 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

History of organ transplantation via the two-way paradigm [PDF]

, 1999
Demetris, AJ, Murase, N, Starzl, TE
core  

The Effect of High Intensity Interval Exercise on Platelet Engraftment in Autologous Bone Marrow Transplantation (BMT). [PDF]

Int J Hematol Oncol Stem Cell Res
Zarekar T, Hajifathali A, Ahmadizad S.
europepmc   +1 more source

Label‐Free Sorting of Human Mesenchymal Stem Cells Using Insulating Dielectrophoresis

ELECTROPHORESIS, EarlyView.
ABSTRACT Human mesenchymal stem cells (hMSCs) are a multipotent yet heterogeneous cell population with immunosuppressive and regenerative properties, making them highly promising for stem cell therapies targeting metabolic diseases. However, the inherent heterogeneity of hMSCs presents challenges for producing consistent therapeutic outcomes ...
Zuri A. Rashad, Kiara L. Lacy, Emmanuel Egun, Jazmine S. Moore, Tayloria N. G. Adams   +4 more
wiley   +1 more source